All News T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

Real-time Estimate Cboe BZX Other stock markets 12:30:29 03/05/2024 am IST			5-day change	1st Jan Change
3.305 ^USD	+10.17%		+20.80%	-47.25%

29/04	Canaccord Genuity Adjusts Price Target on T2 Biosystems to $3 From $12, Maintains Hold Rating	MT
23/04	Top Premarket Decliners	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Canaccord Genuity Adjusts Price Target on T2 Biosystems to $3 From $12, Maintains Hold Rating	29/04	MT
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024	24/04	AQ
Top Premarket Decliners	23/04	MT
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity	12/04	AQ
T2 Biosystems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.	28/03	AQ
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc	28/03	CI
T2 Biosystems, Inc. Reiterates Revenue Guidance for the Year 2024	20/03	CI
Transcript : T2 Biosystems, Inc. - Special Call	20/03
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates	20/03	AQ
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates	20/03	CI
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates	19/03	AQ
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel	18/03	AQ
T2 Biosystems, Inc. Announces Publication of New Study Highlighting Clinical Benefits and Performance of Real-World Use of T2Resistance Panel in Journal of Clinical Microbiology	18/03	CI
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement	12/03	AQ
Transcript : T2 Biosystems, Inc., Q4 2023 Earnings Call, Feb 15, 2024	16/02
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results	16/02	AQ
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity	16/02	AQ
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia	16/02	AQ
T2 Biosystems, Inc. Announces Commercial Expansion Through Distributors in Europe and Asia	16/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

All News

Filters